Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-N-methyl-N-isopropyltryptamine and Related Analogs

IF 4.5 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
ACS Chemical Neuroscience Pub Date : 2026-06-17 Epub Date: 2026-05-27 DOI:10.1021/acschemneuro.6c00083
Grant C. Glatfelter*, Serena S. Schalk, Donna Walther, Alexander D. Maitland, Nicholas R. Gonzalez, John S. Partilla, Nicholas A. Anas, Andrew R. Chadeayne, Marilyn Naeem, David R. Manke, John D. McCorvy and Michael H. Baumann, 
{"title":"Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-N-methyl-N-isopropyltryptamine and Related Analogs","authors":"Grant C. Glatfelter*,&nbsp;Serena S. Schalk,&nbsp;Donna Walther,&nbsp;Alexander D. Maitland,&nbsp;Nicholas R. Gonzalez,&nbsp;John S. Partilla,&nbsp;Nicholas A. Anas,&nbsp;Andrew R. Chadeayne,&nbsp;Marilyn Naeem,&nbsp;David R. Manke,&nbsp;John D. McCorvy and Michael H. Baumann,&nbsp;","doi":"10.1021/acschemneuro.6c00083","DOIUrl":null,"url":null,"abstract":"<p >Tryptamine psychedelics induce psychoactive effects via agonist actions at serotonin 2A receptors (5-HT<sub>2A</sub>), but the compounds are generally nonselective. 4-Methoxy-<i>N</i>-methyl-<i>N</i>-isopropyltryptamine (4-MeO-MiPT) is a 5-HT<sub>2A</sub> agonist which also blocks the 5-HT transporter (SERT) and has blunted visual and other psychedelic effects in humans. Here, we compared the pharmacology of 4-MeO-MiPT, its 4-hydroxy derivative (4-HO-MiPT), and related analogs with <i>N-</i>alkyl or 4-alkoxy variations. We hypothesized that compounds with more potent SERT uptake inhibition would display reduced 5-HT<sub>2A</sub>-mediated psychedelic-like effects in the mouse head twitch response (HTR) model. <i>In vitro</i> target profiling revealed potent and efficacious 5-HT receptor activities for most of the compounds, including 5-HT<sub>2A</sub> receptor agonism (EC<sub>50</sub> = 10–118 nM, <i>E</i><sub>max</sub> = 72–97% 5-HT). Importantly, 4-MeO-MiPT and its <i>N</i>,<i>N</i>-diisopropyl (4-MeO-DiPT) and <i>N</i>-methyl-<i>N</i>-cyclopropyl (4-MeO-McPT) analogs displayed more potent uptake inhibition at SERT (IC<sub>50</sub> = 17–107 nM) than their 4-OH counterparts (IC<sub>50</sub> = 280–423 nM). Studies administering the drugs subcutaneously to C57BL/6J mice revealed that 4-HO- and 4-MeO-MiPT (0.03–30 mg/kg) had similar potencies for inducing HTRs (ED<sub>50</sub> = 0.75 vs 0.97 mg/kg), but 4-MeO-MiPT had reduced efficacy (<i>E</i><sub>max</sub> = 77 vs 34 HTRs/30 min). A similar trend for decreased HTRs was observed for 4-MeO-DiPT and 4-MeO-McPT. Pretreatment with the SERT inhibitor fluoxetine (10 mg/kg) prior to 4-HO-MiPT, 4-HO-DiPT, or 4-HO-McPT reduced the maximal number of HTRs to levels observed for their respective 4-MeO analogs. Overall, our data indicate that 4-MeO-MiPT interacts with 5-HT<sub>2A</sub> and other 5-HT receptors, but the drug also inhibits SERT to reduce the efficacy of psychedelic-like effects in mice. Therefore, 4-MeO-MiPT and other dual 5-HT<sub>2A</sub>/SERT ligands may be therapeutically relevant compounds with reduced potential for traditional acute psychedelic effects.</p>","PeriodicalId":13,"journal":{"name":"ACS Chemical Neuroscience","volume":"17 12","pages":"2348–2363"},"PeriodicalIF":4.5000,"publicationDate":"2026-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.6c00083","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Chemical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acschemneuro.6c00083","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Tryptamine psychedelics induce psychoactive effects via agonist actions at serotonin 2A receptors (5-HT2A), but the compounds are generally nonselective. 4-Methoxy-N-methyl-N-isopropyltryptamine (4-MeO-MiPT) is a 5-HT2A agonist which also blocks the 5-HT transporter (SERT) and has blunted visual and other psychedelic effects in humans. Here, we compared the pharmacology of 4-MeO-MiPT, its 4-hydroxy derivative (4-HO-MiPT), and related analogs with N-alkyl or 4-alkoxy variations. We hypothesized that compounds with more potent SERT uptake inhibition would display reduced 5-HT2A-mediated psychedelic-like effects in the mouse head twitch response (HTR) model. In vitro target profiling revealed potent and efficacious 5-HT receptor activities for most of the compounds, including 5-HT2A receptor agonism (EC50 = 10–118 nM, Emax = 72–97% 5-HT). Importantly, 4-MeO-MiPT and its N,N-diisopropyl (4-MeO-DiPT) and N-methyl-N-cyclopropyl (4-MeO-McPT) analogs displayed more potent uptake inhibition at SERT (IC50 = 17–107 nM) than their 4-OH counterparts (IC50 = 280–423 nM). Studies administering the drugs subcutaneously to C57BL/6J mice revealed that 4-HO- and 4-MeO-MiPT (0.03–30 mg/kg) had similar potencies for inducing HTRs (ED50 = 0.75 vs 0.97 mg/kg), but 4-MeO-MiPT had reduced efficacy (Emax = 77 vs 34 HTRs/30 min). A similar trend for decreased HTRs was observed for 4-MeO-DiPT and 4-MeO-McPT. Pretreatment with the SERT inhibitor fluoxetine (10 mg/kg) prior to 4-HO-MiPT, 4-HO-DiPT, or 4-HO-McPT reduced the maximal number of HTRs to levels observed for their respective 4-MeO analogs. Overall, our data indicate that 4-MeO-MiPT interacts with 5-HT2A and other 5-HT receptors, but the drug also inhibits SERT to reduce the efficacy of psychedelic-like effects in mice. Therefore, 4-MeO-MiPT and other dual 5-HT2A/SERT ligands may be therapeutically relevant compounds with reduced potential for traditional acute psychedelic effects.

5 -羟色胺转运体阻断降低4-甲氧基- n -甲基- n -异丙基色胺和相关类似物的迷幻样作用。
色胺致幻剂通过对5-羟色胺2A受体(5-HT2A)的激动剂作用诱导精神活性作用,但这些化合物通常是非选择性的。4-甲氧基- n -甲基- n -异丙基色胺(4-MeO-MiPT)是一种5-HT2A激动剂,它也阻断5-HT转运体(SERT),并在人类中具有钝化视觉和其他迷幻作用。在这里,我们比较了4-MeO-MiPT,它的4-羟基衍生物(4-HO-MiPT),以及与n -烷基或4-烷氧基变异的相关类似物的药理学。我们假设,在小鼠头抽搐反应(HTR)模型中,具有更强SERT摄取抑制作用的化合物会显示减少的5- ht2a介导的致幻剂样作用。体外靶标分析显示,大多数化合物具有强大而有效的5-HT受体活性,包括5-HT2A受体激动作用(EC50 = 10-118 nM, Emax = 72-97% 5-HT)。重要的是,4-MeO-MiPT及其N,N-二异丙基(4-MeO-DiPT)和N-甲基-N-环丙基(4-MeO-McPT)类似物在SERT上表现出比4-OH类似物(IC50 = 280-423 nM)更有效的摄取抑制(IC50 = 17-107 nM)。皮下给药C57BL/6J小鼠的研究表明,4-HO-和4-MeO-MiPT (0.03 ~ 30 mg/kg)对HTRs的诱导效果相似(ED50 = 0.75 vs 0.97 mg/kg),但4-MeO-MiPT的诱导效果较差(Emax = 77 vs 34 HTRs/ 30min)。4-MeO-DiPT和4-MeO-McPT的HTRs下降趋势相似。在4-HO-MiPT、4-HO-DiPT或4-HO-McPT之前使用SERT抑制剂氟西汀(10 mg/kg)进行预处理,可将htr的最大数量降低到各自4-MeO类似物的水平。总体而言,我们的数据表明,4-MeO-MiPT与5-HT2A和其他5-HT受体相互作用,但该药物也抑制SERT以降低小鼠的迷幻效果。因此,4-MeO-MiPT和其他双5-HT2A/SERT配体可能是治疗相关的化合物,降低了传统急性迷幻作用的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Chemical Neuroscience
ACS Chemical Neuroscience BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
CiteScore
9.20
自引率
4.00%
发文量
323
审稿时长
1 months
期刊介绍: ACS Chemical Neuroscience publishes high-quality research articles and reviews that showcase chemical, quantitative biological, biophysical and bioengineering approaches to the understanding of the nervous system and to the development of new treatments for neurological disorders. Research in the journal focuses on aspects of chemical neurobiology and bio-neurochemistry such as the following: Neurotransmitters and receptors Neuropharmaceuticals and therapeutics Neural development—Plasticity, and degeneration Chemical, physical, and computational methods in neuroscience Neuronal diseases—basis, detection, and treatment Mechanism of aging, learning, memory and behavior Pain and sensory processing Neurotoxins Neuroscience-inspired bioengineering Development of methods in chemical neurobiology Neuroimaging agents and technologies Animal models for central nervous system diseases Behavioral research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书